BioLab Sciences
BioLab Sciences is a privately held Mesa, Arizona-based medical device manufacturer that develops, produces, and distributes wound care products — including the Microlyte antimicrobial matrix line and amnion membrane products — to healthcare providers, distributors, and patients globally.
- Company typePrivate
- Founded-
- HeadquartersMesa, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What BioLab Sciences does
BioLab Holdings, Inc., operating as BioLab Sciences, is a privately held medical device manufacturer headquartered in Mesa, Arizona that develops, manufactures, and commercializes wound care products. The company serves hospitals, clinics, wound care centers, healthcare distributors, and patients with chronic and acute wounds. Its portfolio is organized into two core families: the Microlyte line — featuring Microlyte SAM, a fully synthetic antimicrobial matrix, and Microlyte Painguard for pain management — and the Membranes line, which includes single and dual layer amnion membranes (Membrane Wrap, Membrane Wrap-Lite) plus a specialized Ocular Membrane. BioLab also offers APIs (Active Pharmaceutical Ingredients) as part of its broader medical manufacturing footprint.
The company's revenue model is anchored in proprietary medical device and tissue-based product sales. Pricing is not publicly disclosed and is inferred to be quote-based given the B2B/medical device context. Go-to-market blends a global healthcare distributor network (supported by a dedicated Distributor Portal) with direct enterprise field sales to healthcare providers, supported by patient-facing educational resources on the company's website. Customer segments span institutional buyers (Healthcare Providers, Healthcare Distributors) and end-user patients, reflecting a horizontal segmentation approach.
The company claims AATB (American Association of Tissue Banks) Accreditation and maintains strategic alliances with APIS, Terraplasma Medical, CureVision, and Imbed Biosciences. No founding date, funding history, headcount, management team composition, or disclosed financial metrics are available in the source data, which materially limits visibility into company scale, capital structure, and historical trajectory. BioLab's website is actively maintained and the company appears to be operating and growing, but the absence of publicly verifiable growth signals prevents definitive trajectory classification.
BioLab Sciences firmographics
Firmographics- Name
- BioLab Sciences
- Legal name
- BioLab Holdings, Inc.
- Website
- https://biolabsciences.net
- Company type
- Private
- Operating status
- Operating
- Short description
- BioLab Sciences is a privately held Mesa, Arizona-based medical device manufacturer that develops, produces, and distributes wound care products — including the Microlyte antimicrobial matrix line and amnion membrane products — to healthcare providers, distributors, and patients globally.
- Ownership category
- akta.pro rank
BioLab Sciences industry classification
Industry- Product category
- Advanced Wound Care Products
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE)
- akta.pro secondary industry
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where BioLab Sciences is headquartered
LocationHeadquarters
- HQ city
- Mesa
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BioLab Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Medical Device and Wound Care Product Sales: BioLab Holdings develops, manufactures, and commercializes wound care medical devices and tissue-based products. Revenue is generated through the sale of proprietary wound care products including Microlyte antimicrobial matrices and membrane products to healthcare distributors, providers, and patients.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels1 record
BioLab Sciences product offering
Product offeringCore offering
BioLab Holdings develops, manufactures, and commercializes wound care medical devices and tissue-based products. The portfolio centers on the Microlyte line of fully synthetic antimicrobial matrices (including Microlyte SAM and Microlyte Painguard) and amnion membrane products (Membrane Wrap, Membrane Wrap-Lite, and Ocular Membrane), with Active Pharmaceutical Ingredients (APIs) offered as an additional category. Products are sold to healthcare distributors and institutional providers for the treatment of chronic wounds and post-surgical wound management.
Product overview
BioLab Holdings is a medical manufacturing company that develops, manufactures, and commercializes wound care products. The product portfolio consists of two main categories: Microlyte Products (including Microlyte SAM, a fully synthetic antimicrobial matrix, and Microlyte Painguard) and Membranes (including Ocular Membrane, Membrane Wrap, and Membrane Wrap-Lite, which offer single and dual layer amnion membrane solutions). Additionally, the company offers APIs (Active Pharmaceutical Ingredients). The products are designed to optimize the standard of wound care through innovations grounded in science for treatment of chronic wounds.
Differentiator
Problem solved
Functional benefit
Products and services
- Microlyte SAM Fully synthetic antimicrobial matrix designed for wound care applications, providing clinical performance for chronic wound treatment. Targeted at healthcare providers and distributors serving patients with chronic wounds.
- Microlyte Painguard Antimicrobial wound care product within the Microlyte line, designed for pain management in wound care treatment. Targeted at healthcare providers treating patients with painful wounds.
- Membrane Wrap Dual layer amnion membrane product designed for enhanced wound coverage and healing. Targeted at healthcare providers treating chronic and complex wounds.
- Membrane Wrap - Lite Single layer amnion membrane product designed for wound coverage and healing. Targeted at healthcare providers treating wounds where a single layer membrane is indicated.
- Ocular Membrane Specialized membrane product designed for ocular applications within the membranes product line. Targeted at ophthalmologists and eye care specialists treating ocular wounds.
- APIs (Active Pharmaceutical Ingredients) Active Pharmaceutical Ingredients (APIs) offered by BioLab Holdings as part of its medical manufacturing portfolio. Targeted at pharmaceutical and medical manufacturing customers.
Companies that use BioLab Sciences
Customer profileSegments3 records
Ideal customer profiles2 records
BioLab Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
BioLab Sciences partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered minor.
- APIS (recoverwithapis.com)minorAPIS appears as a partner/clinician-focused organization in the wound care space. The relationship appears to be collaborative in nature with joint clinical focus in wound care recovery.
- Terraplasma MedicalminorTerraplasma Medical is a partner organization in the wound care/medical technology space. The partnership appears focused on advancing wound care solutions and medical technologies.
- Imbed BiosciencesminorImbed Biosciences is a partner organization in the wound care and biomedical space, suggesting potential collaboration on advanced wound care technologies and products.
Scale indicators1 record
Recent moves6 records
Expansion highlights4 records
BioLab Sciences competitors and assessment
Company assessmentDirect peers
- Organogenesis: Organogenesis is a leading regenerative medicine company selling skin substitutes (Apligraf, Dermagraft) and wound care biologics, competing head-to-head with BioLab's amnion membranes and antimicrobial matrices in advanced wound care.
- MiMedx Group: MiMedx develops and distributes placental/amnion membrane allografts (e.g., EpiFix, AmnioFix) for chronic wound care and surgical recovery, directly overlapping with BioLab's Membrane Wrap product line and skin substitute positioning.
Broad incumbents
- Solventum (formerly 3M Health Care): Solventum's Health Care segment includes advanced wound care solutions (3M Veraflo, Promogran) with deep global distribution, competing with BioLab across hospital and home care wound management channels.
- Integra LifeSciences: Integra LifeSciences offers regenerative tissue technologies and wound matrices (Integra Dermal Regeneration Template, PriMatrix) that overlap directly with BioLab's skin substitute and membrane categories.
- Mölnlycke Health Care: Mölnlycke is a major global wound care and surgical solutions provider (Mepilex, Avance, Granudacyn), with broad hospital and distributor networks that compete with BioLab's membrane and antimicrobial portfolio.
- Coloplast: Coloplast's Wound Care division offers a broad portfolio of advanced dressings, skin barriers, and specialty wound care products with global distribution, overlapping with BioLab's distributor-led wound care go-to-market.
- ConvaTec: ConvaTec provides advanced wound dressings, skin care products, and ostomy devices with strong hospital and homecare channels, competing with BioLab in chronic wound management and tissue-based products.
- Smith+Nephew: Smith+Nephew's Advanced Wound Management portfolio (Allevyn, PICO, nanOscale) is one of the largest global wound care franchises, competing across dressings, NPWT, and advanced biologics relevant to BioLab's chronic wound offerings.
Emerging players
- Imbed Biosciences: Imbed Biosciences develops ultrathin antimicrobial wound matrices (Microlyte) - note this appears to share Microlyte branding with BioLab and is also listed as a partner, indicating closely related but competing/collaborating product technology in synthetic antimicrobial wound dressings.
Others
- Cardinal Health (Medical Products): Cardinal Health is a major medical product distributor and manufacturer with wound care offerings, representing both a potential channel partner and adjacent competitor to BioLab's distributor-led go-to-market model.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
BioLab Sciences social profiles
Digital presenceBioLab Sciences compliance and trust
Trust signalCompliance1 record
BioLab Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioLab Sciences leadership team
Management profileNumber of profiles
BioLab Sciences funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioLab Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioLab Sciences
What does BioLab Sciences do?
BioLab Holdings develops, manufactures, and commercializes wound care medical devices and tissue-based products. The portfolio centers on the Microlyte line of fully synthetic antimicrobial matrices (including Microlyte SAM and Microlyte Painguard) and amnion membrane products (Membrane Wrap, Membrane Wrap-Lite, and Ocular Membrane), with Active Pharmaceutical Ingredients (APIs) offered as an additional category. Products are sold to healthcare distributors and institutional providers for the treatment of chronic wounds and post-surgical wound management.
Is BioLab Sciences a public or private company?
BioLab Sciences is a private company. It is classified as unknown and is currently operating.
When was BioLab Sciences founded?
BioLab Sciences was founded in -1.
Where is BioLab Sciences based?
BioLab Sciences is headquartered in Mesa, United States, in the North America region.
How does BioLab Sciences make money?
One revenue line is on record: medical Device and Wound Care Product Sales.
Who are BioLab Sciences's main competitors?
Direct peers on record are Organogenesis and MiMedx Group. Broad incumbents are Solventum (formerly 3M Health Care), Integra LifeSciences, Mölnlycke Health Care, Coloplast, ConvaTec and Smith+Nephew. Imbed Biosciences is listed as an emerging player. Cardinal Health (Medical Products) is listed as an others.
Does BioLab Sciences have an API?
No public API is recorded for BioLab Sciences.
What industry is BioLab Sciences in?
BioLab Sciences's product category is Advanced Wound Care Products. Its primary akta.pro industry code is HLAHALAE, Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts), with a secondary code of HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 325414 and its SIC code is 2836.